アブストラクト
| Title | 直腸癌に対する外科治療 |
|---|---|
| Subtitle | 今月のテーマ (総説) 直腸癌診療の最近の話題 |
| Authors | 川村純一郎1) |
| Authors (kana) | |
| Organization | 1)近畿大学医学部外科学下部消化管部門 |
| Journal | 日本消化器病学会雑誌 |
| Volume | 117 |
| Number | 7 |
| Page | 580-588 |
| Year/Month | 2020 / 7 |
| Article | 報告 |
| Publisher | 日本消化器病学会 |
| Abstract | 「要旨」: 直腸癌に対する外科治療は, 手術術式と医療機器の進歩により, 腫瘍学的根治と患者のQOLの向上を実現してきた. 現在, 直腸癌に対する手術アプローチには, 開腹手術・腹腔鏡手術・ロボット手術・TaTMEの4つがあるが, それぞれ一長一短があり, 明らかな優越性は報告されていない. また癌の進行度・占拠部位, 患者の性別・体型, さらに術者・施設の状況はさまざまであり, 症例ごとにそれぞれの方法のメリット・デメリットを考慮し手術アプローチを選択する必要がある. 癌個別化医療の推進とともに, 直腸癌に対する外科治療も個々の病態に応じてより安全かつ有効な治療を提供することが求められている. |
| Practice | 臨床医学：内科系 |
| Keywords | 直腸癌, 腹腔鏡下手術, ロボット手術, TaTME, 外科治療 |
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
参考文献
- 1) Miles WE:A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon(1908). CA Cancer J Clin 21;361-364:1971
- 2) Heald RJ, Husband EM, Ryall RD:The mesorec-tum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg 69;613-616:1982
- 3) Jacobs M, Verdeja JC, Goldstein HS:Minimally invasive colon resection(laparoscopic colectomy). Surg Laparosc Endosc 1;144-150:1991
- 4) Fleshman J, Sargent DJ, Green E, et al:Clinical Outcomes of Surgical Therapy Study Group. La-paroscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg 246;655-662;discussion 662-664:2007
- 5) Jayne DG, Guillou PJ, Thorpe H, et al:Random-ized trial of laparoscopic-assisted resection of col-orectal carcinoma:3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol 25;3061-3068:2007
残りの27件を表示する
- 6) Kitano S, Inomata M, Mizusawa J, et al:Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer(JCOG0404):a phase 3, rardomised controlled trial. Lancet Gastroenterol Hepatol 2;261-268:2017
- 7) Bonjer HJ, Deijen CL, Abis GA, et al:A random-ized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 372;1324-1332:2015
- 8) Jeong SY, Park JW, Nam BH, et al:Open versus laparoscopic surgery for mid-rectal or Iow-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial):survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 15;767-774:2014
- 9) Stevenson AR, Solomon MJ, Lumley JW, et al:Ef-fect of Laparoscopic-Assisted Resection vs Open Resection on Pathological Outcomes in Rectal Cancer:The ALaCaRT Randomized Clinical Trial. JAMA 314;1356-1363:2015
- 10) Fleshman J, Branda M, Sargent DJ, et al:Effect of Laparoscopic-Assisted Resection vs Open Re-section of Stage II or III Rectal Cancer on Pa-thologic Outcomes:The ACOSOG Z6051 Ran-domized Clinical Trial. JAMA 314;1346-1355:2015
- 11) Stevenson ARL, Solomon MJ, Brown CSB, et al:Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resec-tion for Rectal Cancer:The Australasian Laparo-scopic Cancer of the Rectum Randomized Clinical Trial. Ann Surg 269;596-602:2019
- 12) Fleshman J, Branda ME, Sargent DJ, et al:Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer:Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial. Ann Surg 269;589-595:2019
- 13) Kakeji Y, Takahashi A, Udagawa H, et al:Surgi-cal outcomes in gastroenterological surgery in Ja-pan:Report of National Clinical database 2011-2016. Ann Gastroenterol Surg 2;37-54:2017
- 14) Yamamoto S, Ito M, Okuda J, et al:Laparoscopic surgery for stage 0/I rectal carcinoma:short-term outcomes of a single-arm phase II trial. Ann Surg 258;283-288:2013
- 15) Pigazzi A, Ellenhorn JD, Ballantyne GH, et al:Robotic-assisted laparoscopic low anterior resec-tion with total mesorectal excision for rectal can-cer. Surg Endosc 20;1521-1525:2006
- 16) Jayne D, Pigazzi A. Marshall H, et al:Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparot-omy Among Patients Undergoing Resection for Rectal Cancer:The ROLARR Randomized Clini-cal Trial. JAMA 318;1569-1580:2017
- 17) Kim MJ, Park SC, Park JW, et al:Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer:A Phase II Open Label Prospective Randomized Controlled Trial. Ann Surg 267;243-251:2018
- 18) Prete FP, Pezzolla A, Prete F, et al:Robotic ver-sus laparoscopic minimally invasive surgery for rectal cancer:a systematic review and meta-analysis of randomized controlled trials. Ann Surg 267;1034-1046:2018
- 19) Sylla P, Rattner DW, Delgado S, et al:NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assis-tance. Surg Endosc 24;1205-1210:2010
- 20) 内視鏡外科手術に関するアンケート調査-第14回集計結果報告-. 日本内視鏡外科学会雑誌 23;786-787:2018
- 21) Penna M, Hompes R, Arnold S, et al:TaTME Registry Collaborative. Transanal Total Mesorec-tal Excision:International Registry Results of the First 720 Cases. Ann Surg 266;111-117:2017
- 22) Penna M, Hompes R, Arnold S, et al:Interna-tional TaTME Registry Collaborative. Incidence and Risk Factors for Anastomotic Failure in 1594 Patients Treated bv Transanal Total Mesorectal Excision:Results From the International TaTME Registry. Ann Surg 269;700-711:2019
- 23) Detering R, Roodbeen SX, van Oostendorp SE, et al:Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands:A Propensity Score-Matched Comparison with Conventional Laparo-scopic Total Mesorectal Excision. J Am Coll Surg 228;235-244.e1:2019
- 24) Wasmuth HH, Faerden AE, Myklebust TA, et al:Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 107;121-130:2020
- 25) Roodbeen SX, Spinelli A, Bemelman WA, et al:Local Recurrence After Transanal Total Mesorectal Excision for Rectal Cancer:A Multi-center Cohort Study. Ann Surg 2020[Epub ahead of print]. doi:10.1097/SLA.0000000000003757
- 26) 大腸癌治療ガイドライン医師用, 2019年版, 大腸癌研究会編, 金原出版, 2019
- 27) Fujita S, Mizusawa J, Kanemitsu Y, et al:Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer(JCOG0212):A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg 266;201-207:2017
- 28) Glynne-Jones R, Wyrwicz L, Tiret E, et al:Rectal cancer:ESMO Clinical Practice Guidelines for di-agnosis, treatment and follow-up. Ann Oncol 28(suppl 4);iv22-iv40:2017
- 29) van der Valk MJM, Hilling DE, Bastiaannet E, et al:Long-term outcomes of clinical complete re-sponders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Data-base(IWWD):an international multicentre regis-try study. Lancet 391;2537-2545:2018
- 30) Lee L, de Lacy B, Gomez Ruiz M, et al:A Multi-center Matched Comparison of Transanal and Robotic Total Mesorectal Excision for Mid and Low-rectal Adenocarcinoma. Ann Surg 270;1110-1116:2019
- 31) Simillis C, Lal N, Thoukididou SN, et al:Open Versus Laparoscopic Versus Robotic Versus Transanal Mesorectal Excision for Rectal Can-cer:A Systematic Review and Network Meta-analysis. Ann Surg 270;59-68:2019
- 32) Bell SW, Heriot AG, Warrier SK, et al:Surgical techniques in the management of rectal cancer:a modified Delphi method by colorectal surgeons in Australia and New Zealand. Tech Coloproctol 23;743-749:2019
